IOBT

IO Biotech (IOBT)

IO Biotech Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IOBT

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/08	05 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOBT	IO Biotech Inc
2024/06/08	05 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOBT	IO Biotech Inc
2024/05/23	21 : 30	GlobeNewswire Inc.	IO Biotech to Present at Jefferies Global Healthcare Conference	NASDAQ:IOBT	IO Biotech Inc
2024/05/14	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2024/05/14	21 : 13	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOBT	IO Biotech Inc
2024/05/14	20 : 55	GlobeNewswire Inc.	IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights	NASDAQ:IOBT	IO Biotech Inc
2024/04/25	05 : 30	GlobeNewswire Inc.	IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2024/04/15	21 : 30	GlobeNewswire Inc.	IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness	NASDAQ:IOBT	IO Biotech Inc
2024/04/10	01 : 00	GlobeNewswire Inc.	IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103	NASDAQ:IOBT	IO Biotech Inc
2024/04/05	21 : 30	GlobeNewswire Inc.	IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer	NASDAQ:IOBT	IO Biotech Inc
2024/03/12	05 : 56	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IOBT	IO Biotech Inc
2024/03/07	06 : 11	GlobeNewswire Inc.	IO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2024/03/06	07 : 17	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:IOBT	IO Biotech Inc
2024/03/06	06 : 46	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2024/03/06	06 : 40	GlobeNewswire Inc.	IO Biotech Announces 2023 Fourth-Quarter and Year-End Results	NASDAQ:IOBT	IO Biotech Inc
2024/02/27	06 : 05	GlobeNewswire Inc.	IO Biotech to Present at 44th Annual Cowen Health Care Conference	NASDAQ:IOBT	IO Biotech Inc
2024/01/08	22 : 11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2023/12/21	22 : 30	GlobeNewswire Inc.	IO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket Trial	NASDAQ:IOBT	IO Biotech Inc
2023/11/25	07 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IOBT	IO Biotech Inc
2023/11/14	06 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IOBT	IO Biotech Inc
2023/11/13	22 : 12	GlobeNewswire Inc.	IO Biotech Announces 2023 Third Quarter Results	NASDAQ:IOBT	IO Biotech Inc
2023/11/13	22 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IOBT	IO Biotech Inc
2023/11/13	22 : 00	GlobeNewswire Inc.	IO Biotech Appoints Helen Collins, MD, to its Board of Directors	NASDAQ:IOBT	IO Biotech Inc
2023/11/10	22 : 00	GlobeNewswire Inc.	IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma	NASDAQ:IOBT	IO Biotech Inc
2023/11/09	06 : 30	GlobeNewswire Inc.	IO Biotech Announces Participation in Upcoming Investor Conferences	NASDAQ:IOBT	IO Biotech Inc
2023/11/01	21 : 30	GlobeNewswire Inc.	IO Biotech Presents Three Posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2023/10/23	14 : 00	GlobeNewswire Inc.	Encouraging Preliminary Data from a Phase 2 Trial Evaluating IO102-IO103 in Combination with Pembrolizumab for First-line Treatment of Patients with Non-small Cell Lung Cancer and Squamous Cell Carcinoma of the Head and Neck Presented at the European Socie	NASDAQ:IOBT	IO Biotech Inc
2023/10/04	05 : 30	GlobeNewswire Inc.	IO Biotech Announces Three Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting	NASDAQ:IOBT	IO Biotech Inc
2023/09/13	05 : 06	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	NASDAQ:IOBT	IO Biotech Inc
2023/09/12	21 : 05	GlobeNewswire Inc.	IO Biotech Announces New Data Related to its IO102-IO103 Therapeutic Cancer Vaccine Presented Today at the IASLC 2023 World Conference on Lung Cancer	NASDAQ:IOBT	IO Biotech Inc